Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 112.00
Ask: 113.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.893%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 112.50
ONWD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity/Director/PDMR Shareholding

26 Apr 2024 07:00

RNS Number : 0889M
Onward Opportunities Limited
26 April 2024
 

26 April 2024

 

Onward Opportunities Limited

("ONWD" or the "Company")

 

Issue of Equity and Total Voting Rights

 

Director/PDMR Shareholding

 

Onward Opportunities Limited (AIM: ONWD), the investment company targeting opportunities in smaller companies within the UK, announces that it has made application for 16,848 new ordinary shares in the Company ("New Ordinary Shares") to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 30 April 2024 and the New Ordinary Shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares.

 

On Admission, the Company will have a total of 17,557,378 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 17,557,378 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The New Ordinary Shares will be issued to Dowgate Wealth Limited (the "Portfolio Manager") at an effective issue price per New Ordinary Share of 109.04 pence, being the net asset value per ONWD ordinary share at 31 March 2024, in respect of the Portfolio Manager's performance fee for the year ended 31 December 2023 and pursuant to the Portfolio Management Agreement between the Company and the Portfolio Manager (the "PMA") first disclosed in the Company's AIM Admission Document dated 23 March 2023.

 

In accordance with the terms of the PMA, the Portfolio Manager has agreed to transfer 7,800 New Ordinary Shares issued to the Portfolio Manager to Laurence Hulse, Investment Director of the Portfolio Manager and a PDMR of the Company. The notification below, provided in accordance with the UK Market Abuse Regulation, provides further details in this regard.

 

All of the New Ordinary Shares are subject to an 18-month lock-in period following Admission.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Laurence Hulse

2

Reason for notification

a.

Position/Status

Investment Director of Dowgate Wealth Limited and PDMR

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Onward Opportunities Limited

b.

LEI

213800OP1Q2B3EO9LE92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of nil par value eachISIN: GG00BMZR1514

b.

Nature of the transaction

Issue of new ordinary shares in respect of 2023 portfolio manager performance fee

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

109.04p

 

7,800

 

d.

Aggregated information

- Aggregated Volume

- Price

 Not applicable (Single transaction)

 

e.

Date of the transaction

25 April 2024

f.

Place of the transaction

Outside of a trading venue

 

 

-ENDS-

  

For further information, please contact

 

 

 

 

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

 

Apex Administration (Guernsey) Limited (Company Secretary)

Martin Baxter / Harry Rouillard

 

Tel: +44 (0) 203 5303 150

ool@apexgroup.com

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes/Camilla Hume

 

Tel: +44 (0)20 7397 8900

Dowgate Capital Limited (Joint Broker)

Russell Cooke / Nicholas Chambers

 

Tel: +44 (0)20 3903 7715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQKPBQNBKDPQB
Date   Source Headline
26th Apr 20247:00 amRNSIssue of Equity/Director/PDMR Shareholding
11th Apr 20247:00 amRNSAnnual Results
3rd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20244:51 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSIssue of Equity
5th Mar 20243:21 pmRNSNet Asset Value(s)
22nd Feb 20242:20 pmRNSDirector/PDMR Shareholding
2nd Feb 20247:00 amRNSNet Asset Value(s)
18th Jan 202410:44 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSQuarterly Factsheet – Q4 2023
10th Jan 20247:00 amRNSPortfolio Update
4th Jan 20247:00 amRNSNet Asset Value(s)
18th Dec 202311:26 amRNSHolding(s) in Company
4th Dec 20233:19 pmRNSNet Asset Value(s)
3rd Nov 20233:14 pmRNSNet Asset Value(s)
31st Oct 202312:00 pmRNSTVR & Change of Nominated Adviser and Joint Broker
24th Oct 20237:00 amRNSQuarterly Factsheet - Q3 2023
11th Oct 20235:39 pmRNSHolding(s) in Company
9th Oct 20235:06 pmRNSHolding(s) in Company
5th Oct 20232:54 pmRNSNet Asset Value(s)
4th Oct 20237:00 amRNSIssue of Equity
4th Sep 20237:00 amRNSNet Asset Value(s)
4th Sep 20237:00 amRNSHalf-year Report
3rd Aug 20232:08 pmRNSNet Asset Value(s)
14th Jul 20237:00 amRNSQuarterly Factsheet – Q2 2023
5th Jul 20232:21 pmRNSNet Asset Value(s)
5th Jun 20235:36 pmRNSNet Asset Value(s)
9th May 202310:03 amRNSHolding(s) in Company
5th May 20239:50 amRNSNet Asset Value(s)
31st Mar 202310:54 amRNSHolding(s) in Company
31st Mar 20237:00 amRNSChange of Registered Office
30th Mar 20237:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.